middle.news
Why Did MedAdvisor’s Revenue Halve in Q1 FY26? Inside the US Market Pressures
10:02am on Wednesday 22nd of October, 2025 AEDT
•
Healthcare
Read Story
Why Did MedAdvisor’s Revenue Halve in Q1 FY26? Inside the US Market Pressures
10:02am on Wednesday 22nd of October, 2025 AEDT
Key Points
Q1 FY26 revenue down 52.8% to AUD 9.6 million
US government policy and pharmacy sector challenges weigh heavily
ANZ business divested for AUD 35 million, net cash position strong
Next-gen patient engagement platform launching in Q2 FY26
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MDR
OPEN ARTICLE